drugset / Trial / NCT01352559
Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype
Non-randomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether pharmacogenomic study of bioamine transporters and peripheral lymphatic biomarkers(phenotype) predict antidepressant responsiveness in advance before the appearance of the drug effects until 4\~6 weeks after drug administration.
Timeline
- Start
- 2001-11
- Primary completion
- 2007-03
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | — | — |
| Subject | Milnacipran | Other / unclassified | — | — |
| Subject | Mirtazapine | Other / unclassified | — | — |
| Subject | Nortriptyline | Small molecule | — | — |
| Subject | Paroxetine | Small molecule | — | — |
| Subject | Sertraline | Small molecule | — | — |
| Subject | Venlafaxine | Small molecule | — | — |